TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19561024

Group type: EXPERIMENTAL
Intervention: Bone marrow cells (BMCs) administered with each dose of cardioplegia antegradely into the coronaries
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bone marrow cells (BMCs)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning (IP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (muscles harvested after CPB)
Number of subjects: 44
Study: 17276669

Group type: EXPERIMENTAL
Intervention: Exteriorized uterine repair
Number of subjects: 206

Group type: COMPARATOR
Intervention: In situ uterine repair
Number of subjects: 206
Study: 15757268

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11930742

Group type: COMPARATOR
Intervention: No management after LC (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Absorption of residual CO2 after LC (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: O2 insufflation for three times followed by complete absorption of CO2 after LC (Group C)
Number of subjects: 90
Study: 9391248

Group type: EXPERIMENTAL
Intervention: Blood glucose concentration at 12 mmol/l
Number of subjects: 8
Study: 8009346

Group type: EXPERIMENTAL
Intervention: Education and training program (Group B)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Education and training program (Group C)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Non-elastic sacro-iliac belt
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Weekly physical exercise before pregnancy
Number of subjects: 407

Group type: COMPARATOR
Intervention: Group A (Control)
Number of subjects: 407
Study: 2739575

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MCT
Number of subjects: 10

Group type: COMPARATOR
Intervention: LCT
Number of subjects: 10
Study: 4599671

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 27

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 27
Study: 31659541

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at a dose of 4 J/cm2
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at a dose of 2 J/cm2
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 88
Study: 31172967

Group type: EXPERIMENTAL
Intervention: MobileQuit
Number of subjects: 1271

Group type: COMPARATOR
Intervention: QuitOnline
Number of subjects: 1271
Study: 29241888

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 173
Study: 25922426

Group type: EXPERIMENTAL
Intervention: Prolonged-release melatonin (2 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 16
Study: 24189570

Group type: EXPERIMENTAL
Intervention: Dissonance intervention
Number of subjects: 408

Group type: COMPARATOR
Intervention: Educational brochure control
Number of subjects: 408
Study: 21382896

Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg three times daily) for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18027383

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 10 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dextrose (control)
Number of subjects: 20
Study: 16830289

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha 2a 180 microg s.c. weekly plus ribavirin adjusted for patient's weight
Number of subjects: 74

Group type: COMPARATOR
Intervention: Pegylated interferon alpha 2b 1.5 microg/kg s.c. weekly plus ribavirin adjusted for patient's weight
Number of subjects: 74
Study: 14762633

Group type: COMPARATOR
Intervention: Chloroquine 600 mg (single dose) on the first day, placebo on second and third days (Group CPLA)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Chloroquine 600 mg on first day and 450 mg on second and third days (Group CHLO)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Chloroquine single dose treatment
Number of subjects: 132
Study: 10865316

Group type: EXPERIMENTAL
Intervention: Optic nerve decompression surgery (ONDS)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Careful follow-up
Number of subjects: 258
Study: 9355955

Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic adrenalectomy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Open adrenalectomy (control group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic adrenalectomy (learning curve analysis)
Number of subjects: 99
Study: 8105520

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3758142

Group type: EXPERIMENTAL
Intervention: 32.5 mg urapidil
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 65 mg urapidil
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 130 mg urapidil
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All doses of urapidil
Number of subjects: 9
Study: 31756281

Group type: EXPERIMENTAL
Intervention: Intensive treatment for 3 months
Number of subjects: 65
Study: 28924103

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1578
Study: 27037630

Group type: EXPERIMENTAL
Intervention: Single doses of fluticasone propionate and salmeterol combinations administered by oral inhalation from three different batches.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Replicated batch administered in two treatment periods.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 24732241

Group type: EXPERIMENTAL
Intervention: IV endotoxin (lipopolysaccharide, 4 ng/kg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Endobronchial endotoxin (lipopolysaccharide, 4 ng/kg)
Number of subjects: 15
Study: 23118535

Group type: EXPERIMENTAL
Intervention: Educational and self-efficacy intervention
Number of subjects: 4425

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4425
Study: 20307680

Group type: EXPERIMENTAL
Intervention: Pump infusion system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gravity infusion system
Number of subjects: 24
Study: 17950937

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Interpersonal therapy (IPT)
Number of subjects: 219
Study: 16139772

Group type: EXPERIMENTAL
Intervention: ICU noise and mixed-frequency white noise
Number of subjects: 5

Group type: COMPARATOR
Intervention: ICU noise
Number of subjects: 5

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 5
Study: 11905302

Group type: EXPERIMENTAL
Intervention: AlignRite orthosis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rolyan D‐Ring Long orthosis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rolyan D‐Ring Short orthosis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Custom-made thumb hole design orthosis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Free hand
Number of subjects: 40
Study: 10424184

Group type: EXPERIMENTAL
Intervention: One lift every 8 h
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: One lift every 5 min
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lifting height (F-K, F-S, K-S, F-R, K-R, S-R)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Chinese females
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Chinese males
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Chinese participants
Number of subjects: 41

Group type: COMPARATOR
Intervention: Occidental participants
Number of subjects: 41
Study: 7772439

Group type: EXPERIMENTAL
Intervention: Diamorphine 5 mg in 0.9% saline 5 ml i.v.
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% saline 5 ml i.v. (Control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 2106731

Group type: EXPERIMENTAL
Intervention: Valproate sodium
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 393300

Group type: EXPERIMENTAL
Intervention: Guanethidine and adrenaline formulation (3.0% and 0.5%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Guanethidine and adrenaline formulation (1.0% and 0.2%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lower concentration drops (3.0% and 0.5% or 1.0% and 0.2%)
Number of subjects: 20
Study: 30730000

Group type: EXPERIMENTAL
Intervention: Local skin temperature at 30 °C (Cool)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Local skin temperature at 36 °C (Warm)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Local skin temperature at 33 °C (Neutral)
Number of subjects: 10
Study: 28875257

Group type: EXPERIMENTAL
Intervention: Screening group (intervention) - women invited to DXA scanning based on high risk of future fracture
Number of subjects: 34229

Group type: COMPARATOR
Intervention: Control group - women not invited to DXA scanning
Number of subjects: 34229

Group type: EXPERIMENTAL
Intervention: Intervention group - women who ticked 'not interested in DXA'
Number of subjects: 34229

Group type: EXPERIMENTAL
Intervention: Intervention group - women dropping out after primary acceptance of DXA
Number of subjects: 34229
Study: 25899213

Group type: EXPERIMENTAL
Intervention: Chronic low back pain group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chronic low back pain group (male runners)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy runners group
Number of subjects: 36
Study: 23481668

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 22331684

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: All diet groups
Number of subjects: 322
Study: 19302641

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg.kg(‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Alfentanil 20 microg.kg(‐1)
Number of subjects: 80
Study: 17925866

Group type: EXPERIMENTAL
Intervention: PEV301 (10 microg or 50 microg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: PEV302 (10 microg or 50 microg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combined delivery of PEV301 and PEV302
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: PEV301 (50 microg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: PEV302 (10 microg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (unmodified virosomes)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 46
Study: 15179608

Group type: EXPERIMENTAL
Intervention: Probiotic containing Lactobacillus and Bifidobacterium
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 11470387

Group type: EXPERIMENTAL
Intervention: Ventilation tubes
Number of subjects: 320

Group type: COMPARATOR
Intervention: Watchful waiting (nonrandomized)
Number of subjects: 320
Study: 9504725

Group type: EXPERIMENTAL
Intervention: Bubble oxygenator (Harvey 1700, n = 28)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Membrane oxygenator (Cobe CML, n = 34)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Post-operative EEG deficit
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Neuropsychological performance
Number of subjects: 62
Study: 7520770

Group type: EXPERIMENTAL
Intervention: rhG‐CSF 5 micrograms/kg every 12 hours
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rhG‐CSF 10 micrograms/kg every 12 hours
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rhG‐CSF 1.0, 5.0 or 10.0 micrograms/kg every 24 hours
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rhG‐CSF
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rhG‐CSF 10 micrograms/kg every 24 hours
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 2472722

Group type: EXPERIMENTAL
Intervention: Fibrin adhesive (Beriplast) applied to the gallbladder bed
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no fibrin adhesive)
Number of subjects: 80
Study: 30095858

Group type: EXPERIMENTAL
Intervention: burst-TENS-CT
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: AMF-CT
Number of subjects: 70

Group type: COMPARATOR
Intervention: sham-CT
Number of subjects: 70
Study: 28159819

Group type: EXPERIMENTAL
Intervention: Prediction model using preprocedural clinical variables (13 variables selected from 83)
Number of subjects: 8800

Group type: EXPERIMENTAL
Intervention: Machine learning method of random forest
Number of subjects: 8800
Study: 26244434

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study: 23574713

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid vaginal gel (Hyalofemme)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Estriol cream (Ovestin)
Number of subjects: 144
Study: 22509426

Group type: EXPERIMENTAL
Intervention: Donor bone marrow infusion (DBMI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 40
Study: 18222275

Group type: EXPERIMENTAL
Intervention: Mild hypothermia (32 degrees C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate hypothermia (25 degrees C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long CPB time and long aortic cross‐clamp time
Number of subjects: 30
Study: 15967546

Group type: EXPERIMENTAL
Intervention: Nicotine patches (15 mg/16 hr)
Number of subjects: 40
Study: 12907325

Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg once daily
Number of subjects: 680

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg three times daily
Number of subjects: 680

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 680

Group type: COMPARATOR
Intervention: Nonselective NSAIDs (ibuprofen, naproxen, or diclofenac)
Number of subjects: 680
Study: 10234793

Group type: EXPERIMENTAL
Intervention: P-ESWL (Pulverization, no chemolitholysis)
Number of subjects: 34

Group type: COMPARATOR
Intervention: F-ESWL (fragments <= 4 mm, concomitant oral chemolitholysis)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: P-ESWL
Number of subjects: 34
Study: 8909622

Group type: EXPERIMENTAL
Intervention: SAGE program (all three components: Rites of Passage, summer employment, entrepreneurial experience)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Summer employment and entrepreneurial components only
Number of subjects: 260

Group type: COMPARATOR
Intervention: Delayed program or control condition
Number of subjects: 260
Study: 2062518

Group type: COMPARATOR
Intervention: 50% nitrous oxide/50% oxygen and placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100% oxygen and 20 mg diazepam
Number of subjects: 40

Group type: COMPARATOR
Intervention: 50% nitrous oxide/50% oxygen and 20 mg diazepam
Number of subjects: 40
Study: 6613711

Group type: EXPERIMENTAL
Intervention: Male smoking confederate
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Female smoking confederate
Number of subjects: 56

Group type: COMPARATOR
Intervention: No model present
Number of subjects: 56
Study: 30700328

Group type: EXPERIMENTAL
Intervention: pTVG-HP DNA vaccine and pembrolizumab
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Baseline FLT uptake in the thyroid
Number of subjects: 17
Study: 29336187

Group type: EXPERIMENTAL
Intervention: sirukumab 50 mg every 4 weeks (q4w)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: sirukumab 100 mg every 2 weeks (q2w)
Number of subjects: 168

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 168
Study: 26580978

Group type: EXPERIMENTAL
Intervention: Dexamethasone suspension eye-drops (group A)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Dexamethasone solution eye-drops (group B)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 117
Study: 24701009

Group type: EXPERIMENTAL
Intervention: Bifrontal ECT (BFECT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bitemporal ECT (BTECT)
Number of subjects: 70
Study: 22379064

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 20215457

Group type: EXPERIMENTAL
Intervention: CSII/RT‐CGM with the algorithm
Number of subjects: 60

Group type: COMPARATOR
Intervention: CSII/RT‐CGM without the algorithm
Number of subjects: 60
Study: 17488683

Group type: EXPERIMENTAL
Intervention: Peripheral blood (PB) monitoring for minimal residual disease (MRD)
Number of subjects: 50
Study: 18694046

Group type: EXPERIMENTAL
Intervention: Self administered questionnaire on computer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional paper based method
Number of subjects: 0
Study: 12569085

Group type: EXPERIMENTAL
Intervention: C + AA (hydrocortisone sodium succinate infusion at 80 microg. kg(‐1). h(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: AA (intravenous saline)
Number of subjects: 12
Study: 11126816

Group type: EXPERIMENTAL
Intervention: Tropisetron (2 mg intravenously at induction)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 50
Study: 9175044

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy (50 IU/kg intravenously or 35 IU/kg subcutaneously for the first 6 months, then 20 IU/kg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy
Number of subjects: 33
Study: 1543940

Group type: EXPERIMENTAL
Intervention: Citrated calcium carbimide with relapse prevention counselling
Number of subjects: 56

Group type: COMPARATOR
Intervention: Citrated calcium carbimide with Physician Advice
Number of subjects: 56
Study: 3907677

Group type: EXPERIMENTAL
Intervention: Oxyfedrine 24 mg four times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily
Number of subjects: 0
Study: 30465815

Group type: EXPERIMENTAL
Intervention: 20-min high-intensity cycling exercise
Number of subjects: 29

Group type: COMPARATOR
Intervention: Resting control session
Number of subjects: 29
Study: 29193677

Group type: EXPERIMENTAL
Intervention: Gallic Acid (GA) 15 mg p-1 d-1 for 7 days
Number of subjects: 19
Study: 26891345

Group type: EXPERIMENTAL
Intervention: Sex-related alcohol expectancies (increased riskiness, decreased nervousness, enhanced sexuality)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Delay discounting
Number of subjects: 126
Study: 24717407

Group type: EXPERIMENTAL
Intervention: TIROX regimen (S‐1 + irinotecan + oxaliplatin)
Number of subjects: 60

Group type: COMPARATOR
Intervention: DCF regimen (docetaxel + cisplatin + flurouracil)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TIROX regimen
Number of subjects: 60

Group type: COMPARATOR
Intervention: DCF regimen
Number of subjects: 60
Study: 22200343

Group type: COMPARATOR
Intervention: EBPI brochure (n = 66)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: MMA brochure (n = 66)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Correlation with attitude change
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Correlation with intention change
Number of subjects: 132
Study: 19935115

Group type: EXPERIMENTAL
Intervention: Bandage therapy (BT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Cast therapy (CT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Bandage therapy (BT) and Cast therapy (CT)
Number of subjects: 92
Study: 18565440

Group type: EXPERIMENTAL
Intervention: POWER social marketing campaign
Number of subjects: 3407

Group type: EXPERIMENTAL
Intervention: POWER exposure
Number of subjects: 3407

Group type: COMPARATOR
Intervention: Control (no POWER campaign)
Number of subjects: 3407
Study: 16214916

Group type: EXPERIMENTAL
Intervention: 1,200 mg of elemental calcium daily for 4 years
Number of subjects: 2051

Group type: EXPERIMENTAL
Intervention: 81 mg of aspirin daily for 3 years combined with calcium supplementation
Number of subjects: 2051

Group type: EXPERIMENTAL
Intervention: Baseline dietary calcium intake
Number of subjects: 2051
Study: 12205831

Group type: EXPERIMENTAL
Intervention: CAHPS report
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Medicaid enrollment materials
Number of subjects: 0
Study: 10323511

Group type: EXPERIMENTAL
Intervention: Plasma N-terminal atrial natriuretic peptide prohormone measurement
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Multiple linear regression analysis of hemodynamic and clinical variables
Number of subjects: 68
Study: 7478874

Group type: EXPERIMENTAL
Intervention: Physical practice plus imagery practice
Number of subjects: 32

Group type: COMPARATOR
Intervention: Physical practice only
Number of subjects: 32
Study: 1932261

Group type: EXPERIMENTAL
Intervention: Instrumental and classical conditioning combined
Number of subjects: 50

Group type: COMPARATOR
Intervention: Instrumental conditioning alone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Classical conditioning alone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 50
Study: 6344035

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + Propranolol 80 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31623572

Group type: EXPERIMENTAL
Intervention: Transmuscular QLB (QLB‐3) using 20 ml 0.25% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Posterior QLB (QLB‐2) using 20 ml 0.25% bupivacaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transmuscular QLB (QLB‐3)
Number of subjects: 40
Study: 30160789

Group type: COMPARATOR
Intervention: Intravenous arsenic trioxide (ATO)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Oral Realgar-Indigo naturalis formula (RIF)
Number of subjects: 82
Study: 27434598

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Conjoint Therapy for PTSD (CBCT for PTSD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 40